 |
市場調查報告書
商品編碼
1629636
經導管主動脈瓣置換術市場依手術類型、設備類型、最終用戶和地區分類Transcatheter Aortic Valve Replacement Market, By Procedure Type, By Device Type, By End User, By Geography |
||||||
2024 年全球經導管主動脈瓣置換術市場規模估計為 67.1 億美元，預計到 2031 年將達到 108 億美元，2024 年至 2031 年的複合年成長率為 7%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2023 | 2024 年的市場規模 | 67.1億美元 |
| 效能資料 | 2019 年至 2023 年 | 預測期 | 2024 年至 2031 年 |
| 預測期間 2024 年至 2031 年複合年成長率： | 7.00％ | 2031 年價值預測 | 108億美元 |
過去十年，受全球老年人口不斷成長和主動脈瓣狹窄盛行率不斷上升的推動，全球經導管主動脈瓣置換術術市場迅速成長。 TAVR 手術為患有嚴重主動脈瓣狹窄且接受開胸手術風險較高的患者提供了一種微創治療選擇。在此過程中，透過導管插入折疊式的人工心臟瓣膜，並將其放置在患病的原生主動脈瓣內。這種方法降低了與開胸手術相關的風險，例如嚴重出血、感染疾病和長期住院。隨著越來越多的臨床證據證明 TAVR 的安全性、有效性和持久性，患者的合格標準正在擴大，推動其在北美等主要地區的市場更廣泛的應用。廣泛的技術進步和新產品的核准，特別是在瓣膜輸送系統方面，也有助於推動 TAVR 在全球的普及。
市場動態：
全球經導管主動脈瓣置換術術市場的發展主要受到老年人口快速成長的推動，老年人口更容易罹患主動脈瓣狹窄。全球範圍內預期壽命的增加和人口老化導致需要心臟瓣膜置換術的患者數量顯著增加。 2024年10月，世界衛生組織估計，全球60歲及以上人口預計將在2015年至2050年間加倍，從12％達到22％。心血管疾病負擔的不斷加重和人們對微創手術的認知的不斷提高進一步推動了經導管主動脈瓣置換術的普及。與開胸心臟手術相比，經導管手術更受青睞，因為其恢復時間更短、住院時間更短，且併發症風險更低，尤其是對於高風險患者而言。然而，在大多數人口無法獲得先進心臟治療的新興國家，經導管主動脈瓣置換術的市場發展潛力仍未開發。
本研究的主要特點
本研究報告對全球經導管主動脈置換術市場進行了詳細分析，並提供了預測期（2024-2031 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設基準年為 2023 年。
它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
全球經導管主動脈瓣置換術市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。
研究中涉及的主要企業包括 Edwards Lifesciences Corp.、Medtronic Plc.、Abbott Laboratories.、Boston Scientific Corp.、MicroPort Scientific Corp.、JenaValve Technology GmbH.、Cardiovascular Systems, Inc.、Symetis SA.、Leet Medical Co.Ltd.、Tebburea. 、Biotronik SE &Co.KG. 和 Cook Medical。
本報告提供的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球經導管主動脈瓣置換術市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球經導管主動脈瓣置換術市場的各種策略矩陣來促進決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要進展
- 監管情景
- 產品發布/核准
- PEST分析
- PORTER 分析
- 併購情景
- 產業趨勢
4. 全球經導管主動脈瓣置換術市場，依手術類型，2019 年至 2031 年
- 經股動脈
- 山頂
- 其他方法
5. 全球經導管主動脈瓣置換術市場，依設備類型，2019 年至 2031 年
- 氣囊膨脹閥
- 自膨脹瓣膜
6. 全球經導管主動脈瓣置換術市場，依最終用戶分類，2019 年至 2031 年
- 醫院
- 門診手術中心
- 獨立的心臟導管室
- 其他
7. 2019 年至 2031 年全球經導管主動脈瓣置換術市場（按地區）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第8章 競爭格局
- Edwards Lifesciences Corp.
- Medtronic Plc.
- Abbott Laboratories.
- Boston Scientific Corp.
- MicroPort Scientific Corp.
- JenaValve Technology GmbH.
- Cardiovascular Systems, Inc.
- Symetis SA.
- Lepu Medical Technology Co., Ltd.
- Terumo Corporation.
- Jude Medical（now part of Abbott）.
- AtriCure, Inc.
- Vascular Solutions, Inc.
- Biotronik SE & Co. KG.
- Cook Medical
第 9 章分析師建議
- 命運之輪
- 分析師觀點
- 一致的機會圖
第10章參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
The global transcatheter aortic valve replacement market is estimated to be valued at USD 6.71 Bn in 2024 and is expected to reach USD 10.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 6.71 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 7.00% | 2031 Value Projection: | US$ 10.80 Bn |
The global transcatheter aortic valve replacement market has been growing rapidly over the past decade backed by the rising geriatric population and increasing prevalence of aortic stenosis globally. TAVR procedures offer a minimally invasive treatment option for severe aortic stenosis patients who are at high risk for open-heart surgeries. The technique involves threading a collapsible prosthetic heart valve through a catheter into the body and placing it inside the diseased native aortic valve. This method reduces risks associated with open-heart surgeries such as severe bleeding, infections, and long hospital recovery times. As more clinical evidence demonstrates the safety, efficacy, and longevity of TAVR patient eligibility criteria have expanded, driving wider market adoption in key regions such as North America. Widespread technological advancements especially around valve delivery systems and new product approvals too have boosted the uptake of TAVR globally.
Market Dynamics:
The global transcatheter aortic valve replacement market is primarily driven by the rapidly growing geriatric population base that is more susceptible to aortic stenosis. Rising life expectancy and aging demographics worldwide have significantly upscaled the patient pool requiring heart valve replacements. In October 2024, as per the WHO estimates, the global population aged 60 years and over is projected to double from 12% to 22% between 2015 and 2050. Growing burden of cardiovascular diseases and increasing awareness about minimally invasive procedures have further propelled the adoption of transcatheter aortic valve replacement. Transcatheter approaches are preferred over open-heart surgeries since they offer shortened recovery times, reduced hospital stays, and lower complication risks, especially for high-risk patients. However, the market potential of transcatheter aortic valve replacement is still untapped in developing nations where a majority population lacks access to advanced cardiac care.
Key Features of the Study:
This report provides in-depth analysis of the global transcatheter aortic valve replacement market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global transcatheter aortic valve replacement market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Edwards Lifesciences Corp., Medtronic Plc., Abbott Laboratories., Boston Scientific Corp., MicroPort Scientific Corp., JenaValve Technology GmbH., Cardiovascular Systems, Inc., Symetis SA., Lepu Medical Technology Co., Ltd., Terumo Corporation., St. Jude Medical (now part of Abbott)., AtriCure, Inc., Vascular Solutions, Inc., Biotronik SE & Co. KG., and Cook Medical
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global transcatheter aortic valve replacement market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transcatheter aortic valve replacement market
Market Segmentation
- By Procedure Type Insights (Revenue, USD Bn, 2019 - 2031)
- Transfemoral
- Transapical
- Other Approaches
- By Device Type Insights (Revenue, USD Bn, 2019 - 2031)
- Balloon-Expandable Valves
- Self-Expanding Valves
- By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Ambulatory Surgical Centers
- Independent Cardiac Catheterization Labs
- Others
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Edwards Lifesciences Corp.
- Medtronic Plc.
- Abbott Laboratories.
- Boston Scientific Corp.
- MicroPort Scientific Corp.
- JenaValve Technology GmbH.
- Cardiovascular Systems, Inc.
- Symetis SA.
- Lepu Medical Technology Co., Ltd.
- Terumo Corporation.
- Jude Medical (now part of Abbott).
- AtriCure, Inc.
- Vascular Solutions, Inc.
- Biotronik SE & Co. KG.
- Cook Medical
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Transcatheter Aortic Valve Replacement Market, By Procedure Type
- Global Transcatheter Aortic Valve Replacement Market, By Device Type
- Global Transcatheter Aortic Valve Replacement Market, By End User
- Global Transcatheter Aortic Valve Replacement Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Transcatheter Aortic Valve Replacement Market, By Procedure Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Transfemoral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Transapical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Other Approaches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Transcatheter Aortic Valve Replacement Market, By Device Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Balloon-Expandable Valves
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Self-Expanding Valves
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Transcatheter Aortic Valve Replacement Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Independent Cardiac Catheterization Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Transcatheter Aortic Valve Replacement Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country /Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Edwards Lifesciences Corp.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic Plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corp.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MicroPort Scientific Corp.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- JenaValve Technology GmbH.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cardiovascular Systems, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Symetis SA.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lepu Medical Technology Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corporation.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jude Medical (now part of Abbott).
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AtriCure, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vascular Solutions, Inc.
- Biotronik SE & Co. KG.
- Cook Medical
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
2025-2033 年經導管肺動脈瓣市場（按技術、原料、應用、最終用戶和地區分類）
經導管主動脈瓣置換術市場規模、佔有率、趨勢分析報告：按植入程序、材料、機制、最終用途、地區、細分預測，2025-2030 年
美國經導管栓塞和封堵 (TEO) 設備市場：Medtech 360
亞太地區經導管栓塞和封堵 (TEO) 設備市場：Medtech 360
歐洲經導管栓塞和封堵 (TEO) 設備市場：Medtech 360
經導管器材市場規模、佔有率和趨勢分析報告：2025-2030 年按產品、應用、地區和細分市場進行的預測
經導管器材市場：按產品、按應用分類 - 2025-2030 年全球預測
經導管栓塞和阻塞設備市場：按產品、應用和最終用戶分類 - 全球預測 2025-2030 年
經導管肺動脈瓣市場：按技術、原料、應用和最終用途分類 - 全球預測 2025-2030
全球經導管肺動脈瓣市場 (2024-2028)